Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

IRMD stock hub

IRADIMED CORPORATION has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IRMDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IRMD

In the news

Latest news · IRMD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E43.3

P25 12.3P50 18.4P75 33.1

Trailing P/E47.2

P25 14.9P50 23.2P75 38.5

ROE25

P25 -105.6P50 -46.5P75 -3.1

ROIC51.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IRMD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

262

Groups with data

Currency

USD

Showing 262 of 262 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001325618
Company name	IRADIMED CORPORATION
Country	United States
Country code	US
Cusip	46266A109
Employees	166
Employees Change	6%
Employees Change Percent	3.75
Enterprise value	$1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2014-07-16
Isin	US46266A1097
Last refreshed	2026-05-10
Market cap	$1.1B
Market cap category	Small-Cap
Price	$86.29
Price currency	USD
Rev Per Employee	519,771.08x
Sector	Healthcare
Sic	3841
Symbol	IRMD
Website	https://www.iradimed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.14%
EV Earnings	44.33x
EV Sales Forward	14.69x
EV/EBIT	37.44x
EV/EBITDA	35.62x
EV/FCF	42.76x
EV/Sales	12.13x
FCF yield	2.22%
Forward P/E	43.25x
P/B ratio	11.2x
P/E ratio	47.16x
P/S ratio	12.78x
PE Ratio10 Y	61.67x
PE Ratio3 Y	38.48x
PE Ratio5 Y	42.6x
PS Forward	15.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.4%
EBITDA Margin	34.05%
FCF margin	28.37%
Gross margin	76.84%
Gross Profit	$66.3M
Gross Profit Growth	14.69%
Gross Profit Growth Q	13.28%
Gross Profit Growth3 Y	14.97%
Gross Profit Growth5 Y	22.36%
Net Income	$23.6M
Net Income Growth	19.34%
Net Income Growth Q	24.13%
Net Income Growth Quarters	6%
Net Income Growth Years	5%
Net Income Growth3 Y	19.75%
Net Income Growth5 Y	88.71%
Pretax Margin	34.98%
Profit Margin	27.36%
Profit Per Employee	$142,235
Profitable Years	14
ROA	16.17
Roa5y	12.77
ROCE	27.33
ROE	25.04
Roe5y	20.87
ROIC	51.09
Roic5y	69.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	19.02%
Cagr1y	71.72%
Cagr3y	24.3%
Cagr5y	26.63%
Div CAGR3	5.7%
EPS Growth	18.07
EPS Growth Q	22.07
EPS Growth Quarters	6
EPS Growth Years	5
EPS Growth3 Y	18.84
EPS Growth5 Y	86.69
FCF Growth	67.61%
FCF Growth Q	1,225.55%
FCF Growth3 Y	57.81%
FCF Growth5 Y	36.55%
OCF Growth	11.19%
OCF Growth Q	93.15%
OCF Growth10 Y	12.36%
OCF Growth3 Y	29.71%
OCF Growth5 Y	39.07%
Revenue Growth	14.81x
Revenue Growth Q	12.65x
Revenue Growth Quarters	21x
Revenue Growth Years	5x
Revenue Growth3 Y	15.18x
Revenue Growth5 Y	21.74x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.8
Assets	$114.4M
Cash	$56.4M
Current Assets	$86.4M
Current Liabilities	$12.1M
Equity	$98.5M
Liabilities	$15.9M
Long Term Assets	$28M
Long Term Liabilities	$3.8M
Net Cash	$56.4M
Net Cash By Market Cap	$5.11
Net Cash Growth	12.14%
Net Debt EBITDA	$-1.92
Net Debt Equity	$-0.57
Net Debt FCF	$-2.3
Tangible Book Value	$95.2M
Tangible Book Value Per Share	$7.45
WACC	9.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.13
Inventory Turnover	1.78
Net Working Capital	$17.9M
Quick ratio	5.76
Working Capital	$74.3M
Working Capital Turnover	$1.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.48%
Dividend Growth	93.75%
Dividend Growth Years	1%
Dividend per share	$0.8
Dividend Years	5
Dividend Yield	0.93%
Ex Div Date	2026-05-15
Last Dividend	$0.2
Payout Frequency	Quarterly
Payout Ratio	67.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	470.08%
1Y total return	71.66%
200-day SMA	86.8
3Y total return	92.07%
50-day SMA	94.98
50-day SMA vs 200-day SMA	50over200
5Y total return	225.56%
All Time High	107.9
All Time High Change	-20.03%
All Time High Date	2026-02-10
All Time Low	6.26
All Time Low Change	1,278.35%
All Time Low Date	2014-09-03
ATR	3.42
Beta	0.91
Beta1y	0.21
Beta2y	0.64
Ch YTD	-11.3
High	87.39
High52	107.9
High52 Date	2026-02-10
High52ch	-20.03%
Low	85.65
Low52	50.88
Low52 Date	2025-05-23
Low52ch	69.59%
Ma50ch	-9.15%
Premarket Change Percent	1.75
Premarket Price	$88.26
Premarket Volume	311
Price vs 200-day SMA	-0.59%
RSI	39.53
RSI Monthly	62.85
RSI Weekly	42
Sharpe ratio	1.57x
Sortino ratio	3.08
Total Return	0.44%
Tr YTD	-11.13
Tr1m	-7.71%
Tr1w	-0.99%
Tr3m	-9.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$0.44
Earnings EPS Estimate Growth	4.76
Earnings Revenue Estimate	21,378,000x
Earnings Revenue Estimate Growth	9.57x
Operating Income	$28M
Operating Income Growth	23.42
Operating Income Growth Q	33.23
Operating Income Growth3 Y	19.07
Operating Income Growth5 Y	56.43
Operating margin	32.4
Price target	$116
Price Target Change	$34.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,301,006%
Float Percent	64.94%
Shares Insiders	35.06%
Shares Institutions	59.95%
Shares Out	12,783,035
Shares Qo Q	-0.04%
Shares Yo Y	0.48%
Short Float	6.51%
Short Ratio	5.57
Short Shares	4.23

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$21.7M
Average Volume	109,815.3x
Bv Per Share	7.71
CAPEX	$-4.5M
Ch10y	420.1
Ch1m	-7.71
Ch1w	-0.99
Ch1y	69.15
Ch3m	-10.09
Ch3y	84.29
Ch5y	197
Ch6m	2.32
Change	-0.52%
Change From Open	-1.26
Close	86.74
Days Gap	0.75
Depreciation Amortization	1,427,000
Dollar Volume	4,612,882.4
Earnings Date	2026-05-01
Earnings Time	bmo
EBIT	$28M
EBITDA	$29.4M
EPS	$1.83
F Score	5
FCF	$24.5M
FCF EV Yield	2.34x
FCF Per Share	$1.91
Financing CF	-17,929,000
Fiscal Year End	December
Founded	1,992
Graham Number	17.81264
Graham Upside	-79.36
Income Tax	$6.6M
Investing CF	-4,973,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-01
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-06
Lynch Fair Value	$45.75
Lynch Upside	-46.98
Ma150	92.61
Ma150ch	-6.82%
Ma20	88.67
Ma20ch	-2.69%
Net CF	6,043,000
Next Earnings Date	2026-07-31
Open	87.39
Optionable	Yes
P FCF Ratio	45.07
P OCF Ratio	38.11
Payment Date	2026-05-29
Position In Range	36.49
Ppne	24,225,000
Pre Close	86.74
Price Date	2026-05-08
Price EBITDA	$37.54
Ptbv Ratio	11.58
Relative Volume	0.49x
Revenue	86,282,000x
SBC By Revenue	3.22x
Share Based Comp	2,777,000
Tax By Revenue	7.62x
Tax Rate	21.78%
Tr6m	3.26%
Us State	Florida
Volume	53,461
Z Score	40.06

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

IRMD dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.9%

$0.80 annual per share

Payout ratio

+67.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+0.4%

Next ex-dividend date: 2026-05-15

Performance

IRMD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IRMD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+59.9%

Float: +64.9% of shares outstanding

Insider ownership

+35.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IRMD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.5

Neutral momentum band

Price vs 200-day MA

-0.6%

50/200-day relationship not available

Beta (5Y)

0.91

Moves roughly with the market

Sharpe ratio

1.57

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IRMD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IRMD stock rating?

IRADIMED CORPORATION is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IRMD analysis?

The full report lives at /stocks/IRMD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IRMD?

The latest report frames IRMD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IRMD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.